The four citation patterns behind most CAPA-related warning letters, and what an effectiveness check actually needs to demonstrate.
This course covers FDA's expectations for a CAPA system, the citation patterns most often found in CAPA-related warning letters, and what an effectiveness check actually needs to demonstrate, not just confirm that an action happened. It also covers how CAPA differs from a simple corrective action closed at the source, and how to build a CAPA program that improves over time instead of accumulating open items.
CAPA deficiencies were cited in 26 of 44 FDA drug warning letters in FY2025, making it one of the single most common warning letter themes. A CAPA system that closes items without verifying they actually worked is not a quality system, it is a documentation exercise.
Completion certificate, PDF slide download, and access to the complete GMP course library from day one.
Start this course →